Category Archives: Hypertension

The research report on Global Hypertension and Heart Failure Drugs Market is a professional detailing of the important elements that drive the Hypertension and Heart Failure Drugs market growth rate and revenue statistics. Continue reading →

Patients with end-stage renal disease (ESRD) have a cardiovascular mortality about 15-30 times the general population and this is reduced by about 70% with renal transplant. Dobutamine stress echocardiography (DSE) is commonly performed for preoperative cardiac evaluation before renal transplantation. Continue reading →

Medical practitioners have been told to consider choosing antihypertensive medications with the lowest possible potential for adverse drug effects such as sexual dysfunctions among adult hypertensive men in order to attain an optimum balance between antihypertensive efficacy and adequate preservation of sexual functions. Experts in an assessment of the effect of prescribed antihypertensive medications on sexual dysfunctions in men, including decreased libido and intercourse dissatisfaction, indicate that these drugs can cause medication-induced sexual dysfunctions but to various degrees. In a new study, the highest occurrence of sexual dysfunctions was associated with calcium-channel blockers in 32 (20.1 per cent) patients, followed by diuretics in 27 (17.0 per cent) and, angiotensin-converting enzyme inhibitors in 20 (12.6 per cent) patients. Continue reading →

An informative study on the Pulmonary Arterial Hypertension (PAH) Market from 2020-2027 has lately released for the database of Coherent Market Insights that helps by making business conclusions and shape the future of the organizations. Individual analysis of top regions and countries like North America, Europe, Asia-Pacific, South America, Asia-Pacific, Middle East & Africa and Latin America and the rest of the world is conducted. Industry overview, product definitions, and growth status are presented Continue reading →

November 26, 2020 12:50 ET | Source: insightSLICE PUNE, India, Nov. 26, 2020 (GLOBE NEWSWIRE) -- The Global Pharmacovigilance Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, supply chain analysis, competitive landscape, and market composition analysis. The pharmacovigilance market size was estimated to be US$ 4.2 billion and is expected to reach US$ 18.7 billion by 2030 at a CAGR of 14.6% through 2030 Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Acromegaly and Gigantism - Epidemiology Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. Continue reading →

A new research document with title Global Hypertension And Heart Failure Treatment Market Report covering detailed analysis, Competitive landscape, forecast and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific, South America, Middle East and Africa. The report will help user gain market insights, future trends and growth prospects for forecast to 2027. Continue reading →

Closed Loop Medicine has recruited its first patient into a novel PhIV precision medicine interventional clinical trial for patients with high blood pressure. The UK clinical stage therapeutics company is developing drug + digital combination products. Continue reading →

About 35 percent of Americans have metabolic syndrome, a group of risk factors that raises the risk of cardiovascular disease the leading cause of death in the United States. Continue reading →

In this Phase 2, multicenter, randomized, double-blind study (NCT02702388), 152 patients with RAI-refractory DTC were randomized to receive a daily oral dose of either 24 mg or 18 mg of LENVIMA. Continue reading →